CD10-equipped melanoma cells acquire highly potent tumorigenic activity

A plausible explanation of their significance for a poor prognosis

Junna Oba, Takeshi Nakahara, Akiko Hashimoto-Hachiya, Min Liu, Takeru Abe, Akihito Hagihara, Takehiko Yokomizo, Masutaka Furue

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

CD10 has been widely used in cancer diagnosis. We previously demonstrated that its expression in melanoma increased with tumor progression and predicted poor patient survival. However, the mechanism by which CD10 promotes melanoma progression remains unclear. In order to elucidate the role of CD10 in melanoma, we established CD10-overexpressing A375 melanoma cells and performed DNA microarray and qRT-PCR analyses to identify changes in the gene expression profile. The microarray analysis revealed that upregulated genes in CD10-A375 were mostly involved in cell proliferation, angiogenesis, and resistance to apoptosis; down-regulated genes mostly belonged to the categories associated with cell adhesion and migration. Accordingly, in functional experiments, CD10-A375 showed significantly greater cell proliferation in vitro and higher tumorigenicity in vivo; CD10 enzymatic inhibitors, thiorphan and phosphoramidon, significantly blocked the tumor growth of CD10-A375 in mice. In migration and invasion assays, CD10-A375 displayed lower migratory and invasive capacity than mock-A375. CD10 augmented melanoma cell resistance to apoptosis mediated by etoposide and gemcitabine. These findings indicate that CD10 may promote tumor progression by regulating the expression profiles of genes related to cell proliferation, angiogenesis, and resistance to apoptosis.

Original languageEnglish
Article numbere0149285
JournalPloS one
Volume11
Issue number2
DOIs
Publication statusPublished - Feb 1 2016

Fingerprint

Cell proliferation
melanoma
prognosis
Tumors
Melanoma
Genes
Microarrays
Apoptosis
gemcitabine
Thiorphan
cell proliferation
neoplasms
apoptosis
Cell Proliferation
angiogenesis
Transcriptome
Cell adhesion
Etoposide
cells
Neoplasms

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Cite this

CD10-equipped melanoma cells acquire highly potent tumorigenic activity : A plausible explanation of their significance for a poor prognosis. / Oba, Junna; Nakahara, Takeshi; Hashimoto-Hachiya, Akiko; Liu, Min; Abe, Takeru; Hagihara, Akihito; Yokomizo, Takehiko; Furue, Masutaka.

In: PloS one, Vol. 11, No. 2, e0149285, 01.02.2016.

Research output: Contribution to journalArticle

Oba, Junna ; Nakahara, Takeshi ; Hashimoto-Hachiya, Akiko ; Liu, Min ; Abe, Takeru ; Hagihara, Akihito ; Yokomizo, Takehiko ; Furue, Masutaka. / CD10-equipped melanoma cells acquire highly potent tumorigenic activity : A plausible explanation of their significance for a poor prognosis. In: PloS one. 2016 ; Vol. 11, No. 2.
@article{753973e17c634a32915e564e2f386ab3,
title = "CD10-equipped melanoma cells acquire highly potent tumorigenic activity: A plausible explanation of their significance for a poor prognosis",
abstract = "CD10 has been widely used in cancer diagnosis. We previously demonstrated that its expression in melanoma increased with tumor progression and predicted poor patient survival. However, the mechanism by which CD10 promotes melanoma progression remains unclear. In order to elucidate the role of CD10 in melanoma, we established CD10-overexpressing A375 melanoma cells and performed DNA microarray and qRT-PCR analyses to identify changes in the gene expression profile. The microarray analysis revealed that upregulated genes in CD10-A375 were mostly involved in cell proliferation, angiogenesis, and resistance to apoptosis; down-regulated genes mostly belonged to the categories associated with cell adhesion and migration. Accordingly, in functional experiments, CD10-A375 showed significantly greater cell proliferation in vitro and higher tumorigenicity in vivo; CD10 enzymatic inhibitors, thiorphan and phosphoramidon, significantly blocked the tumor growth of CD10-A375 in mice. In migration and invasion assays, CD10-A375 displayed lower migratory and invasive capacity than mock-A375. CD10 augmented melanoma cell resistance to apoptosis mediated by etoposide and gemcitabine. These findings indicate that CD10 may promote tumor progression by regulating the expression profiles of genes related to cell proliferation, angiogenesis, and resistance to apoptosis.",
author = "Junna Oba and Takeshi Nakahara and Akiko Hashimoto-Hachiya and Min Liu and Takeru Abe and Akihito Hagihara and Takehiko Yokomizo and Masutaka Furue",
year = "2016",
month = "2",
day = "1",
doi = "10.1371/journal.pone.0149285",
language = "English",
volume = "11",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "2",

}

TY - JOUR

T1 - CD10-equipped melanoma cells acquire highly potent tumorigenic activity

T2 - A plausible explanation of their significance for a poor prognosis

AU - Oba, Junna

AU - Nakahara, Takeshi

AU - Hashimoto-Hachiya, Akiko

AU - Liu, Min

AU - Abe, Takeru

AU - Hagihara, Akihito

AU - Yokomizo, Takehiko

AU - Furue, Masutaka

PY - 2016/2/1

Y1 - 2016/2/1

N2 - CD10 has been widely used in cancer diagnosis. We previously demonstrated that its expression in melanoma increased with tumor progression and predicted poor patient survival. However, the mechanism by which CD10 promotes melanoma progression remains unclear. In order to elucidate the role of CD10 in melanoma, we established CD10-overexpressing A375 melanoma cells and performed DNA microarray and qRT-PCR analyses to identify changes in the gene expression profile. The microarray analysis revealed that upregulated genes in CD10-A375 were mostly involved in cell proliferation, angiogenesis, and resistance to apoptosis; down-regulated genes mostly belonged to the categories associated with cell adhesion and migration. Accordingly, in functional experiments, CD10-A375 showed significantly greater cell proliferation in vitro and higher tumorigenicity in vivo; CD10 enzymatic inhibitors, thiorphan and phosphoramidon, significantly blocked the tumor growth of CD10-A375 in mice. In migration and invasion assays, CD10-A375 displayed lower migratory and invasive capacity than mock-A375. CD10 augmented melanoma cell resistance to apoptosis mediated by etoposide and gemcitabine. These findings indicate that CD10 may promote tumor progression by regulating the expression profiles of genes related to cell proliferation, angiogenesis, and resistance to apoptosis.

AB - CD10 has been widely used in cancer diagnosis. We previously demonstrated that its expression in melanoma increased with tumor progression and predicted poor patient survival. However, the mechanism by which CD10 promotes melanoma progression remains unclear. In order to elucidate the role of CD10 in melanoma, we established CD10-overexpressing A375 melanoma cells and performed DNA microarray and qRT-PCR analyses to identify changes in the gene expression profile. The microarray analysis revealed that upregulated genes in CD10-A375 were mostly involved in cell proliferation, angiogenesis, and resistance to apoptosis; down-regulated genes mostly belonged to the categories associated with cell adhesion and migration. Accordingly, in functional experiments, CD10-A375 showed significantly greater cell proliferation in vitro and higher tumorigenicity in vivo; CD10 enzymatic inhibitors, thiorphan and phosphoramidon, significantly blocked the tumor growth of CD10-A375 in mice. In migration and invasion assays, CD10-A375 displayed lower migratory and invasive capacity than mock-A375. CD10 augmented melanoma cell resistance to apoptosis mediated by etoposide and gemcitabine. These findings indicate that CD10 may promote tumor progression by regulating the expression profiles of genes related to cell proliferation, angiogenesis, and resistance to apoptosis.

UR - http://www.scopus.com/inward/record.url?scp=84960539259&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960539259&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0149285

DO - 10.1371/journal.pone.0149285

M3 - Article

VL - 11

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 2

M1 - e0149285

ER -